MedPath

Galderma Laboratorium GmbH

🇩🇪Germany
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.galderma.de

Clinical Trials

4

Active:0
Completed:4

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Amorolfine Hydrochloride Cream

Product Name
罗每乐
Approval Number
H20140118
Approval Date
Jun 19, 2020
NMPA

Clinical Trials

ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis

Completed
Conditions
Actinic Keratoses
First Posted Date
2023-02-13
Last Posted Date
2024-02-23
Lead Sponsor
Galderma Laboratorium GmbH
Target Recruit Count
224
Registration Number
NCT05725213
Locations
🇩🇪

Klinikum Vest GmbH, Recklinghausen, Germany

Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne

Completed
Conditions
Acne Vulgaris
First Posted Date
2015-01-14
Last Posted Date
2016-02-17
Lead Sponsor
Galderma Laboratorium GmbH
Target Recruit Count
1388
Registration Number
NCT02338544

Long-term Study of Epiduo in Patients With Moderate to Severe Acne

Completed
Conditions
Acne Vulgaris
First Posted Date
2012-06-13
Last Posted Date
2016-02-17
Lead Sponsor
Galderma Laboratorium GmbH
Target Recruit Count
6036
Registration Number
NCT01618773

Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne

Completed
Conditions
Acne
First Posted Date
2010-10-13
Last Posted Date
2016-02-17
Lead Sponsor
Galderma Laboratorium GmbH
Target Recruit Count
3113
Registration Number
NCT01220102

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.